Researchers at the Icahn School of Medicine at Mount Sinai have found that small populations of pancreatic cancer cells can create localized immune-protective niches that shield tumors from immune attack. The finding could open new avenues for making immunotherapy more effective against one of the deadliest forms of cancer.
Pancreatic Cancer Cells Create Immune Shields, Study Suggests New Immunotherapy Approaches
Researchers at the Icahn School of Medicine at Mount Sinai discovered that pancreatic cancer cells can create immune-protective niches, potentially improving immunotherapy effectiveness. This research could have implications for cancer treatment globally, including in Iran, where cancer rates are rising.
👥 Key Players
📰 What Happened
Researchers discovered that pancreatic cancer cells can create protective environments that shield tumors from the immune system. This could enhance the effectiveness of immunotherapy for treating pancreatic cancer.
- Pancreatic cancer is one of the deadliest forms of cancer.
- The discovery may lead to new treatment strategies that improve patient outcomes.
💡 Why It Matters
📚 Background
Pancreatic cancer is known for its poor prognosis and resistance to conventional therapies, making research into new treatments critical.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%